Early endeavors in the 1990s, utilizing healthy myoblasts to restore dystrophin expression in patients with DMD, were unsuccessful, albeit more recent trials reported better outcomes (18–20). This evidence concerns the gene DMD and Duchenne muscular dystrophy.